Citadel Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Buy |
|
|||||
|
2025
Q1 | $3.39M | Sell |
|
|||||
|
2024
Q4 | $7.23M | Buy |
|
|||||
|
2024
Q3 | $15M | Sell |
|
|||||
|
2024
Q2 | $14.7M | Buy |
|
|||||
|
2024
Q1 | $23M | Buy |
|
|||||
|
2023
Q4 | $9.97M | Buy |
|
|||||
|
2023
Q3 | $4.28M | Sell |
|
|||||
|
2023
Q2 | $10.9M | Buy |
|
|||||
|
2023
Q1 | $9.46M | Buy |
|
|||||
|
2022
Q4 | $14.3M | Buy |
|
|||||
|
2022
Q3 | $8.81M | Buy |
|
|||||
|
2022
Q2 | $8.73M | Sell |
|
|||||
|
2022
Q1 | $16.3M | Buy |
|
|||||
|
2021
Q4 | $10.1M | Sell |
|
|||||
|
2021
Q3 | $10.6M | Sell |
|
|||||
|
2021
Q2 | $59.6M | Sell |
|
|||||
|
2021
Q1 | $69.4M | Sell |
|
|||||
|
2020
Q4 | $101M | Sell |
|
|||||
|
2020
Q3 | $104M | Sell |
|
|||||
|
2020
Q2 | $112M | Buy |
|
|||||
|
2020
Q1 | $50.4M | Buy |
|
|||||
|
2019
Q4 | $16.6M | Buy |
|
|||||
|
2019
Q3 | $8.92M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $15.3M | Sell |
|
|||||
|
2018
Q4 | $15.9M | Buy |
|
|||||
|
2018
Q3 | $12.8M | Buy |
|
|||||
|
2018
Q2 | $1.22M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $63K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $63K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $49K | Buy |
|